Skye Bioscience, Redx Pharma To Combine To Operate As Fibrx Therapeutics
Skye Bioscience, Inc. (SKYE), a biotechnology company, and privately held Redx Pharma announced a definitive transaction agreement to combine the companies and form Fibrx Therapeutics, a fibrosis-focused company expected to trade on the Nasdaq. Transaction …